For the quickest way to join, simply enter your email below and get access. We will send a confirmation and sign you up to our newsletter to keep you updated on all your gaming news.
Some call it the most important promo in professional wrestling history — and honestly they might be right. Either way, one thing we can say with certainty is that it's exactly 30 years today since ...
Casey Gallagher, MD, is a board-certified dermatologist and clinical professor based in Colorado. Valacyclovir may be easier to take than acyclovir because of its simpler dosing schedule. Both ...
To begin their journeys in this year's World Cup, Iraq and Norway will share the pitch at 6 p.m. ET from Gillette Stadium. For the first time since 1986, Iraq will be present at the FIFA World Cup.
India made a statement in their opening match of the Women's T20 World Cup 2026, overpowering Pakistan by 64 runs at Edgbaston in a contest dominated by Smriti Mandhana's elegant batting and Deepti ...
Maymo’s animal-loving family watches their dogs react to a fruit crush experiment that turns into a messy and unpredictable prank challenge. Israel, Hezbollah agree to ceasefire starting on Friday - ...
NEW DELHI: Left-arm spinner Manav Suthar announced his arrival on the Test stage in stunning fashion, weaving a web around Afghanistan's batters as India registered the biggest victory in their Test ...
India beat Afghanistan by an innings and 300 runs, their biggest Test win, surpassing their previous record of an innings and 272 runs against the West Indies in 2018. India registered a commanding ...
India won the off Test against Afghanistan by an innings and 300 runs after bowling out the visitors twice on day three here on Monday. Following on, Afghanistan were bundled out for 112, worse then ...
Incyte INCY6.87%increase; up pointing triangle has agreed to buy Vega Therapeutics for up to $2 billion in a deal that expands the biopharmaceutical company’s hematology portfolio into bleeding ...
June 8 (Reuters) - Incyte (INCY.O), opens new tab said on Monday it will buy Vega Therapeutics, a wholly owned subsidiary of privately held Star Therapeutics, in a deal ‌worth up to $2 billion, ...
Bill Meury, Incyte's chief executive. Incyte has agreed to buy Star Therapeutics subsidiary Vega Therapeutics for $1.25 billion upfront, adding a late-stage drug candidate for bleeding disorders.